Skip to content
10-Q

Quarterly Report

NPS PHARMACEUTICALS INC

0001136261-14-000357

← back to feed
Filed
Aug 6, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Jul 30, 2014 106.56M sh
Shares Diluted Q2 2014 · Jun 30, 2014 110.5M sh
Shares Diluted Q2 2014 · Jun 30, 2014 105.22M sh
Shares Diluted Q2 2014 · Jun 30, 2013 97.32M sh
Shares Diluted Q2 2014 · Jun 30, 2013 92.89M sh
Operating Cash Flow Q2 2014 · Jun 30, 2014 −$12.75M
Operating Cash Flow Q2 2014 · Jun 30, 2013 −$18.16M
Long Term Debt Q2 2014 · Jun 30, 2014 $107.48M
Long Term Debt Q2 2014 · Dec 31, 2013 $123.64M
Short Term Debt Q2 2014 · Jun 30, 2014 $9.27M
Short Term Debt Q2 2014 · Dec 31, 2013 $8.75M
Cash And Equivalents Q2 2014 · Jun 30, 2014 $53.31M
Cash And Equivalents Q2 2014 · Dec 31, 2013 $51.2M
Cash And Equivalents Q2 2014 · Jun 30, 2013 $70.19M
Cash And Equivalents Q2 2014 · Mar 31, 2013 $19.36M
Cash And Equivalents Q2 2014 · Dec 31, 2012 $17.47M
Stockholders Equity Q2 2014 · Jun 30, 2014 $129.01M
Stockholders Equity Q2 2014 · Dec 31, 2013 $104.89M
Current Liabilities Q2 2014 · Jun 30, 2014 $43.04M
Current Liabilities Q2 2014 · Dec 31, 2013 $58.41M
Total Liabilities Q2 2014 · Jun 30, 2014 $157.96M
Total Liabilities Q2 2014 · Dec 31, 2013 $187.33M
Current Assets Q2 2014 · Jun 30, 2014 $253.8M
Current Assets Q2 2014 · Dec 31, 2013 $258.75M
Total Assets Q2 2014 · Jun 30, 2014 $286.97M
Total Assets Q2 2014 · Dec 31, 2013 $292.22M
Eps Diluted Q2 2014 · Jun 30, 2014 $0.02
Eps Diluted Q2 2014 · Jun 30, 2014 −$0.04
Eps Diluted Q2 2014 · Jun 30, 2013 −$0.13
Eps Diluted Q2 2014 · Jun 30, 2013 −$0.22
Eps Basic Q2 2014 · Jun 30, 2014 $0.02
Eps Basic Q2 2014 · Jun 30, 2014 −$0.04
Eps Basic Q2 2014 · Jun 30, 2013 −$0.13
Eps Basic Q2 2014 · Jun 30, 2013 −$0.22
Sga Expense Q2 2014 · Jun 30, 2014 $26.45M
Sga Expense Q2 2014 · Jun 30, 2014 $51M
Sga Expense Q2 2014 · Jun 30, 2013 $14.47M
Sga Expense Q2 2014 · Jun 30, 2013 $28.67M
Rd Expense Q2 2014 · Jun 30, 2014 $21.15M
Rd Expense Q2 2014 · Jun 30, 2014 $41.71M
Rd Expense Q2 2014 · Jun 30, 2013 $30.89M
Rd Expense Q2 2014 · Jun 30, 2013 $46.58M
Net Income Q2 2014 · Jun 30, 2014 $1.99M
Net Income Q2 2014 · Jun 30, 2014 −$4.58M
Net Income Q2 2014 · Jun 30, 2013 −$12.39M
Net Income Q2 2014 · Jun 30, 2013 −$20.19M
Operating Income Q2 2014 · Jun 30, 2014 $5.79M
Operating Income Q2 2014 · Jun 30, 2014 $2.84M
Operating Income Q2 2014 · Jun 30, 2013 −$9.32M
Operating Income Q2 2014 · Jun 30, 2013 −$13.85M
Cost Of Revenue Q2 2014 · Jun 30, 2014 $2.74M
Cost Of Revenue Q2 2014 · Jun 30, 2014 $4.61M
Cost Of Revenue Q2 2014 · Jun 30, 2013 $473K
Cost Of Revenue Q2 2014 · Jun 30, 2013 $538K
Revenue Q2 2014 · Jun 30, 2014 $56.13M
Revenue Q2 2014 · Jun 30, 2014 $100.17M
Revenue Q2 2014 · Jun 30, 2013 $36.51M
Revenue Q2 2014 · Jun 30, 2013 $61.94M